Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is anticipated to issue its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.9250 per share and revenue of $1.2186 billion for the quarter.
Novozymes A/S Trading Up 3.4%
NVZMF opened at $61.41 on Monday. Novozymes A/S has a 12 month low of $53.68 and a 12 month high of $75.97. The business’s 50-day moving average price is $62.40 and its 200-day moving average price is $62.39.
About Novozymes A/S
Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.
Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing.
Further Reading
- Five stocks we like better than Novozymes A/S
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
